{"prompt": "['B. Braun Medical Inc.', 'OPM-G-H-1506', 'Prontosan', 'Protocol Amendment 2', '13.2.1', 'Regulatory Guidelines', '47', '13.2.2', 'Institutional Review Board', '47', '13.2.3', 'Informed Consent', '47', '13.3', 'Data Handling', '48', '13.4', 'Source Documents', '48', '13.5', 'Record Retention', '48', '13.6', 'Monitoring', '48', '13.7', 'Quality Control and Quality Assurance', '49', '13.8', 'Protocol Amendment and Protocol Deviation', '49', '13.8.1', 'Protocol Amendment', '49', '13.8.2', 'Protocol Deviations', '49', '13.9', 'Ethical Considerations', '49', '13.10', 'Financing and Insurance', '49', '13.11 Publication Policy', '50', '14', 'REFERENCES', '51', '15', 'APPENDICES', '53', '14 November 2018', 'Page 19']['B. Braun Medical Inc.', 'OPM-G-H-1506', 'Prontosan', 'Protocol Amendment 2', 'IN-TEXT TABLES', 'Table 1', 'Schedule of Assessments', '35', 'Table 2', 'Clinical Laboratory Assessments', '43', 'Table 3', 'Classification of Adverse Events by Intensity', '44', '14 November 2018', 'Page 20']['B. Braun Medical Inc.', 'OPM-G-H-1506', 'Prontosan', 'Protocol Amendment 2', '3', 'LIST OF ABBREVIATIONS', 'Abbreviation', 'Definition', 'ADE', 'Adverse device effect', 'AE', 'Adverse event', 'CFR', 'Code of Federal Regulations', 'eCRF', 'Electronic case report form', 'EDC', 'Electronic data capture', 'FDA', 'Food and Drug Administration', 'GCP', 'Good clinical practice', 'HbA1c', 'Glycated hemoglobin', 'HIPAA', 'Health Insurance Portability Accountability Act', 'ICF', 'Informed Consent Form', 'IFU', 'Instructions for Use', 'IRB', 'Institutional Review Board', 'PHMB', 'Polyaminopropyl biguanide (polyhexanide)', 'QoL', 'Quality of life', 'SAE', 'Serious adverse event', 'SAP', 'Statistical Analysis Plan', 'SD', 'Standard deviation', 'SE', 'Standard error', 'SUSAR', 'Suspected unexpected serious adverse reaction', 'TEAE', 'Treatment-emergent adverse event', 'TIME', 'Tissue, Infection/Inflammation, Moisture, Edge', '14 November 2018', 'Page 21']\n\n###\n\n", "completion": "END"}